Blood Cancer Institute Directors & Members
Working in a highly collaborative manner across Montefiore Einstein Cancer Center, global leaders in blood cancer research and care are driving advances in better understanding, preventing, and treating MDS, AML, and myriad other blood cancers. Much of the power of the Blood Cancer Institute derives from the multidisciplinary perspectives, insights, and tools that the members provide.
Blood Cancer Institute Directors
Under the leadership of Marina Konopleva, MD, PhD, Ulrich Steidl, MD, PhD, and Amit Verma, MD, the Blood Cancer Institute is making great strides in expanding treatment options for people with blood cancers.
Marina Konopleva, MD, PhD
Director, Leukemia Program
Ulrich G. Steidl, MD, PhD
Deputy Director, and Associate Director for Basic Science, Montefiore Einstein Cancer Center
Amit K. Verma, MD
Associate Director, Translational Science, Montefiore Einstein Cancer Center
Blood Cancer Institute Members
The more than 20 members of the Blood Cancer Institute help shape and drive basic and translational research in blood cancers.
Teresa V. Bowman, PhD
Associate Professor, Department of Developmental & Molecular Biology
Dennis L. Cooper, MD
Director, Transplant and Cell Therapy
David R. Fooksman, PhD
Associate Professor, Department of Pathology
Keisuke Ito, MD, PhD
Associate Professor, Department of Cell Biology
Maria Marianovich, PhD
Assistant Professor, Department of Cell Biology
Satish K. Nandakumar, MBBS, PhD
Assistant Professor, Department of Cell Biology
Nishi Shah, MD
Attending
Kristy R. Stengel, PhD
Assistant Professor, Department of Cell Biology
Britta Will, Ph.D.
Associate Professor, Department of Oncology (Medical Oncology)
B. Hilda Ye, PhD
Associate Professor, Department of Cell Biology